Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity
暂无分享,去创建一个
U. Schlötzer-Schrehardt | J. Winkler | C. Becker | J. Klucken | J. Schlachetzki | W. Xiang | H. Meixner | Stefanie Menges | Anna-Carin Hoffmann
[1] T. Golde,et al. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α‐synuclein , 2014, Journal of neurochemistry.
[2] G. Braus,et al. Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation , 2014, PLoS genetics.
[3] J. Winkler,et al. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment , 2014, Autophagy.
[4] H. Lashuel,et al. The H50Q Mutation Enhances α-Synuclein Aggregation, Secretion, and Toxicity* , 2014, The Journal of Biological Chemistry.
[5] E. Eisenmesser,et al. Residue Histidine 50 Plays a Key Role in Protecting α-Synuclein from Aggregation at Physiological pH* , 2014, The Journal of Biological Chemistry.
[6] Saikat Ghosh,et al. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro. , 2013, Biochemistry.
[7] D. Berg,et al. SNCA: Major genetic modifier of age at onset of Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[8] M. Farrer,et al. Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[9] T. Schäffer,et al. Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity , 2013, Molecular and Cellular Neuroscience.
[10] Christos Proukakis,et al. A novel α-synuclein missense mutation in Parkinson disease , 2013, Neurology.
[11] He-Jin Lee,et al. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein. , 2013, Antioxidants & redox signaling.
[12] J. Hardy,et al. α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? , 2013, Acta Neuropathologica.
[13] B. Hyman,et al. Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway , 2012, Autophagy.
[14] A. Brice,et al. What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.
[15] Fred H. Gage,et al. In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.
[16] M. Ekberg,et al. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties. , 2011, Free radical biology & medicine.
[17] H. Jäckle,et al. Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models , 2009, The EMBO journal.
[18] E. Waxman,et al. Molecular mechanisms of alpha-synuclein neurodegeneration. , 2009, Biochimica et biophysica acta.
[19] H. Ischiropoulos,et al. Molecular Neurodegeneration BioMed Central Review , 2009 .
[20] Henning Stahlberg,et al. The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.
[21] D. D. Di Monte,et al. Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation* , 2007, Journal of Biological Chemistry.
[22] H. Inoko,et al. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. , 2006, Human molecular genetics.
[23] Isidre Ferrer,et al. Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease , 2005, Journal of neuropathology and experimental neurology.
[24] A Dürr,et al. Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[25] Philippe Amouyel,et al. α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[26] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[27] C. Becker,et al. Conserved High Affinity Ligand Binding and Membrane Association in the Native and Refolded Extracellular Domain of the Human Glycine Receptor α1-Subunit* , 2004, Journal of Biological Chemistry.
[28] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[29] K. Uchida,et al. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. , 2003, Progress in lipid research.
[30] T. Montine,et al. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans , 2002, Neuroscience Letters.
[31] J Q Trojanowski,et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.
[32] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[33] N. Hattori,et al. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Schapira,et al. A Novel Alpha-Synuclein Missense Mutation in Parkinson's Disease , 2012 .
[35] H. Lashuel,et al. Provided for Non-commercial Research and Educational Use Only. Not for Reproduction, Distribution or Commercial Use. Author's Personal Copy Role of Post-translational Modifications in Modulating the Structure, Function and Toxicity of A-synuclein: Implications for Parkinson's Disease Pathogenesis an , 2022 .
[36] D. D. Di Monte,et al. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. , 2007, The Journal of biological chemistry.
[37] A Dürr,et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. , 2004, Lancet.
[38] Philippe Amouyel,et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.
[39] A. Singleton,et al. alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.
[40] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[41] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[42] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.